Canada markets closed

Avid Bioservices, Inc. (CDMO)

NasdaqCM - NasdaqCM Real Time Price. Currency in USD
Add to watchlist
10.23-0.09 (-0.87%)
At close: 04:00PM EDT
10.49 +0.26 (+2.54%)
After hours: 07:42PM EDT
Full screen
Trade prices are not sourced from all markets
Previous Close10.32
Open10.60
Bid10.20 x 400
Ask10.25 x 400
Day's Range10.11 - 10.78
52 Week Range4.07 - 13.22
Volume922,319
Avg. Volume1,136,645
Market Cap650.435M
Beta (5Y Monthly)1.36
PE Ratio (TTM)N/A
EPS (TTM)-2.23
Earnings DateSept 05, 2024 - Sept 09, 2024
Forward Dividend & YieldN/A (N/A)
Ex-Dividend DateN/A
1y Target Est12.50
  • Insider Monkey

    Does Avid Bioservices (CDMO) have Hidden Potential Despite Current Weakness?

    Laughing Water Capital, an investment management company, released its second-quarter 2024 investor letter. A copy of the letter can be downloaded here. In the second quarter, Class A interests in Laughing Water Capital returned about 2.5% bringing year-to-date returns to 11.1%. The SP500TR and R2000 returned 4.3% and -3.3% in the second quarter and 15.3% […]

  • GlobeNewswire

    Avid Bioservices Reports Financial Results for Fourth Quarter and Fiscal Year Ended April 30, 2024

    -- Recorded Fourth Quarter Revenue of $43.0 Million – Highest in Company History -- -- Signed $30 Million in Net New Business Resulting in Backlog of $193 Million -- -- New Mammalian and Cell and Gene Therapy Facilities Fully Operational and in Service; Capital Expenditure Associated with Three-Year Expansion Program Completed -- -- FY 2025 Revenue Guidance of Between $160 Million and $168 Million -- TUSTIN, Calif., July 02, 2024 (GLOBE NEWSWIRE) -- Avid Bioservices, Inc. (NASDAQ: CDMO), a dedic

  • GlobeNewswire

    Avid Bioservices to Report Financial Results for Quarter and Fiscal Year Ended April 30, 2024, After Market Close on July 2, 2024

    TUSTIN, Calif., July 01, 2024 (GLOBE NEWSWIRE) -- Avid Bioservices, Inc. (NASDAQ:CDMO), a dedicated biologics contract development and manufacturing organization (CDMO) working to improve patient lives by providing high quality services to biotechnology and pharmaceutical companies, today announced that it will report financial results for the quarter and fiscal year ended April 30, 2024, on July 2, 2024, after market close and will host a webcast at 1:30 PM Pacific Time (4:30 PM Eastern Time).